Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PIKTOR (sapanisertib + serabelisib) with paclitaxel in advanced endometrial cancer
NCT06463028Phase 2Recruiting
- Sponsor
- Faeth Therapeutics
- Start
- Dec 2024
- Primary completion
- Sep 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of serabelisib in endometrial cancer (EC), sponsored by Faeth Therapeutics. Started Dec 2024; status: recruiting.
02
Drugs
serabelisib
03
Conditions
endometrial cancer (EC)
Beyond the preview
Go deeper on NCT06463028.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06463028.